(Q40127412)

English

Malignant lymphoproliferative diseases induced by Epstein-Barr virus in immunodeficient patients, including X-linked, cytogenetic, and familial syndromes

scientific article published on November 1, 1981

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

Europe PubMed Central

Malignant lymphoproliferative diseases induced by Epstein-Barr Virus in immunodeficient patients, including X-linked, cytogenetic, and familial syndromes (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Malignant lymphoproliferative diseases induced by Epstein-Barr virus in immunodeficient patients, including X-linked, cytogenetic, and familial syndromes (English)

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Epstein–Barr virus

1 reference

based on heuristic

inferred from title

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

author name string

D. T. Purtilo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6274510

13 September 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6274510

13 September 2023

publication date

1 November 1981

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:0165460881900194?httpAccept=text/xml

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

https://api.elsevier.com/content/article/PII:0165460881900194?httpAccept=text/plain

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Cancer Genetics and Cytogenetics

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

251-268

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

On some Morbid Appearances of the Absorbent Glands and Spleen

1

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

A critical analysis of the classifications of non-Hodgkin's lymphomas

3

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Epstein-Barr-virus-induced oncogenesis in immune-deficient individuals

8

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Immune and non-immune control of neoplastic development: contrasting effects of host and tumor evolution

9

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

HLA-restricted T-cell recognition of Epstein–Barr virus-infected B cells

10

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Occurrence of malignancy in immunodeficiency diseases. A literature review

11

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Genetically determined immunodeficiency diseases (GDID) and malignancy: report from the immunodeficiency--cancer registry

12

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Malignancies associated with immunosuppressive or cytotoxic therapy

13

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Deficient Natural Killer Cell Activity in X-Linked Lymphoproliferative Syndrome

14

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Antibody responses to Epstein-Barr virus in families with the X-linked lymphoproliferative syndrome

15

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Immunopathology of infectious mononucleosis and other complications of Epstein-Barr virus infections

16

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Immunodiagnosis and immunopathogenesis of the X-linked recessive lymphoproliferative syndrome

17

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Fatal infectious mononucleosis: a critical review

19

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Epstein-Barr-Virus Immunity and Tissue Distribution in a Fatal Case of Infectious Mononucleosis

21

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Fatal Lymphoma after Transplantation of Cultured Thymus in Children with Combined Immunodeficiency Disease

22

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Diffuse polyclonal B-cell lymphoma during primary infection with Epstein-Barr virus

24

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Tumorigenicity of human hematopoietic cell lines in athymic nude mice

28

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Persistent Epstein-Barr virus infection in a child with hypergammaglobulinaemia and immunoblastic proliferation associated with a selective defect in immune interferon secretion

29

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Chédiak-Higashi gene in humans. II. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function

30

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Dissociation of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity in kidney allograft recipients receiving high-dose immunosuppressive therapy

31

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Immunological Bases for Superior Survival of Females

40

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Editorial: Do human tumors show a chromosome pattern specific for each etiologic agent?

42

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Virus-associated hemophagocytic syndromeA benign histiocytic proliferation distinct from malignant histiocytosis

44

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

The pathogenesis of Hodgkin's disease

45

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Occupational handling of chemicals preceding Hodgkin's disease in men

47

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Lymphomas and occupational benzene exposure

48

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Hodgkin's disease in siblings

49

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Immunodeficiency in Hodgkin's disease and its relation to prognosis

50

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Lymphocyte Reactivity in Hodgkin's Disease: A Lymphocyte Civil War

51

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Hodgkin's disease and anergy

52

1 reference

10.1016/0165-4608(81)90019-4

https://api.crossref.org/works/10.1016/0165-4608(81)90019-4

13 September 2023

Identifiers

10.1016/0165-4608(81)90019-4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40127412&oldid=1973762705"